GlassScriptPhysician profile
Erik Scott Barrett
NPI 1386699882
$1,956.60
in general payments reported to CMS, 2019-2025
14 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $21.03 · 2021: $846 · 2022: $221 · 2023: $245 · 2024: $257 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $766.71 | 2021-2024 | Lensar Laser System |
| Alcon Vision LLC | $545.09 | 2019-2025 | Clareon Panoptix Pro, Lensx, Ora System Verifeye |
| Johnson & Johnson Surgical Vision, INC. | $127.86 | 2019-2025 | Baerveldt Glaucoma Implant (250) |
| Lombart Brothers, INC. | $113.98 | 2024 | Opd-III |
| Allergan, INC. | $95.08 | 2021-2022 | |
| Abbvie INC. | $75.77 | 2022-2025 | Alphagan P, Lumigan |
| Carl Zeiss Meditec USA, INC. | $56.20 | 2022-2023 | Lumera 700, Artevo 800 |
| Sun Pharmaceutical Industries INC. | $52.56 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $34.53 | 2022 | |
| Ivantis, INC | $21.03 | 2020 | |
| Novartis Pharmaceuticals Corporation | $19.13 | 2022 | |
| Glaukos Corporation | $18.76 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| New World Medical,INC. | $15.40 | 2023 | |
| Thea Pharma INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.